Wachtell, Paul Weiss Advise On Pfizer's $7.3B Obesity Path
By Al Barbarino · September 22, 2025, 4:06 PM EDT
Pfizer Inc. will acquire Metsera Inc. for $4.9 billion in cash, as the U.S. pharmaceutical giant bets on the biotech firm's experimental treatments for obesity and cardiometabolic diseases, the companies said...
To view the full article, register now.